Value of molecular markers for administration of anticoagulant therapy after heart valve replacement
Dahm, M.; Lotz, J.; Hafner, G.; Oelert, H.; Prellwitz, W.
Zeitschrift für Kardiologie 87(Suppl 4): 42-45
1998
ISSN/ISBN: 0300-5860 PMID: 9857466 Document Number: 491595
In a prospective study, 39 patients following aortic or mitral valve replacement underwent investigation of molecular markers (prothrombin fragment F1+2, Factor II) in the initial phase of oral anticoagulation therapy (OAT). The results demonstrate that, despite INR being in the depicted range, the levels of the molecular markers remained high, indicating an increased risk of thromboembolic events. This leads to the conclusion that molecular markers are superior to INR in the monitoring of the early phase of OAT.
Document emailed within 1 workday
Related Documents
Yao, H.; Miyamoto, T.; Yamashita, K.; Mukai, M.; Wada, T.; Yamamura, M.; Nakagawa, T.; Ryomoto, M. 2000: Necessity of permanent anticoagulant therapy for isolated mitral valve replacement with bioprosthetic heart valve to prevent the postoperative thromboembolic complications Kyobu Geka. Japanese Journal of Thoracic Surgery 53(4): 337-340Stenzinger, W. 1998: Intensity of oral anticoagulant therapy after heart valve replacement Zeitschrift für Kardiologie 87(Suppl 4): 37-41
Height, S.E.; Smith, M.P. 1999: Strategems for anticoagulant therapy following mechanical heart valve replacement Journal of Heart Valve Disease 8(6): 662-664
Ishibashi, Y.; Aoki, H.; Ohba, J.; Kamikubo, Y.; Morimoto, K.; Kumasaka, A. 1996: PT-INR as a parameter for anticoagulant therapy after valve replacement surgery Kyobu Geka. Japanese Journal of Thoracic Surgery 49(11): 906-908
Mori, T.; Asano, M.; Ohtake, H.; Bitoh, A.; Sekiguchi, S.; Matsuo, Y.; Aiba, M.; Yamada, M.; Kawada, T.; Takaba, T. 2002: Anticoagulant therapy after prosthetic valve replacement -optimal PT-INR in Japanese patients- Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 8(2): 83-87
Saha, P.K.; Rakshit, B.M.; Jana, N.; Dutta, S.; Roy, S.B.; Sengupta, G. 2011: Management of abnormal uterine bleeding in women with mechanical heart valve prosthesis and anticoagulant therapy Journal of the Indian Medical Association 109(12): 908-911
Minami, K.; Ohlmeier, H.; Körner, M.M.; Gleichmann, U.; Körfer, R. 1987: Long-term results following heart valve replacement with the Omniscience prosthesis: can heart valve replacement with this prosthesis be recommended? Helvetica Chirurgica Acta 54(3): 267-275
Kanaoka, Y.; Tanemoto, K.; Murakami, T.; Kuroki, K. 2000: Thromboembolic and bleeding complications in patients treated with oral anticoagulant therapy after mechanical heart valve prostheses implantation Kyobu Geka. Japanese Journal of Thoracic Surgery 53(9): 754-758
Washio, M.; Sakashita, I.; Nakamura, C.; Ohtani, S.I.; Asano, K.I.; Matsuzawa, T.; Nishida, Y. 1978: A new anticoagulant medication in cardiac valve replacement Journal of Cardiovascular Surgery 19(5): 455-463
Tanaka, N.; Yamaguchi, T.; Ohno, T.; Kazui, T.; Ohori, K.; Kitano, I.; Abe, T.; Komatsu, S.; Wada, J. 1983: The results of long-term follow-up study for 445 cases of valve replacement with various kinds of cardiac prostheses--comparison of the clinical results among the groups using different types of valves and with or without postoperative anticoagulant therapy Nihon Kyobu Geka Gakkai 31(2): 152-160
Sethi, G.K.; Miller, D.C.; Souchek, J.; Oprian, C.; Henderson, W.G.; Hassan, Z.; Folland, E.; Khuri, S.; Scott, S.M.; Burchfiel, C. 1987: Clinical, hemodynamic, and angiographic predictors of operative mortality in patients undergoing single valve replacement. Veterans Administration Cooperative Study on Valvular Heart Disease Journal of Thoracic and Cardiovascular Surgery 93(6): 884-897
Gschwandtner, M.E.; Eichinger, S.; Hütter, D.; Korninger, L.; Lechner, K.; Panzer, S.; Pabinger, I. 1996: Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 7(3): 325-330
1970: Prosthetic heart valve replacement, with special reference to the ball type valve Kyobu Geka. Japanese Journal of Thoracic Surgery 23(1): 71-73
Remadi, J.P.; Duveau, D. 2004: Long-term results of mechanical valve replacement: isolated mitral valve replacement and mitral-aortic valve replacement Journal of Heart Valve Disease 13(Suppl 1): S26
Idir, M.; Madonna, F.; Roudaut, R. 1999: Collapse and massive pulmonary edema secondary to thrombosis of a mitral mechanical heart valve prosthesis during low-molecular weight heparin therapy Journal of Heart Valve Disease 8(3): 303-304
Ibarra-Pérez, C.; Argüero, R. 1973: The anticoagulant management in patients with heart valve prosthesis La Prensa Medica Mexicana 38(1): 17-19
Emery, R.W.; Arom, K.V.; Kshettry, V.R.; Kroshus, T.J.; Von, R.; Kersten, T.E.; Lillehei, T.J.; Nicoloff, D.M.; Erickson, C.A. 2002: Decision-making in the choice of heart valve for replacement in patients aged 60-70 years: twenty-year follow up of the St. Jude Medical aortic valve prosthesis Journal of Heart Valve Disease 11(Suppl 1): S37-S44
Jacovella, G.; Pace, F.; Rabitti, G. 1975: Anticoagulant treatment in pregnancy: study of 11 patients with heart valve prostheses La Clinica Terapeutica 73(2): 147-153
Judkiewicz, L.; Kałuzna, J.; Pajszczyk-Kieszkiewicz, T.; Pracka, H.; Moll, J.; Zasłonka, J.; Iwaszkiewicz-Zasłonkowa, A. 1979: Anticoagulant treatment of surgical and pregnant patients with heart valve prosthesis Polski Tygodnik Lekarski 34(41): 1573-1576
Zasłonka, J.; Stefaniak, B.; Jaszewski, R.; Ostrowski, S.; Wojtasik, L.; Kesiak, J. 1993: Early and late results of simultaneous and multiple artificial valve replacement in patients with multiple heart valve defects Polski Tygodnik Lekarski 48(3-4): 58-60